Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 2
2003 3
2004 3
2005 1
2006 2
2007 3
2008 2
2009 1
2010 5
2011 3
2012 1
2013 2
2014 5
2015 3
2016 3
2017 4
2018 3
2019 4
2020 12
2021 9
2022 8
Text availability
Article attribute
Article type
Publication date

Search Results

68 results
Results by year
Filters applied: . Clear all
Page 1
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.
Louapre C, Collongues N, Stankoff B, Giannesini C, Papeix C, Bensa C, Deschamps R, Créange A, Wahab A, Pelletier J, Heinzlef O, Labauge P, Guilloton L, Ahle G, Goudot M, Bigaut K, Laplaud DA, Vukusic S, Lubetzki C, De Sèze J; Covisep investigators, Derouiche F, Tourbah A, Mathey G, Théaudin M, Sellal F, Dugay MH, Zéphir H, Vermersch P, Durand-Dubief F, Françoise R, Androdias-Condemine G, Pique J, Codjia P, Tilikete C, Marcaud V, Lebrun-Frenay C, Cohen M, Ungureanu A, Maillart E, Beigneux Y, Roux T, Corvol JC, Bordet A, Mathieu Y, Le Breton F, Boulos DD, Gout O, Guéguen A, Moulignier A, Boudot M, Chardain A, Coulette S, Manchon E, Ayache SS, Moreau T, Garcia PY, Kumaran D, Castelnovo G, Thouvenot E, Taithe F, Poupart J, Kwiatkowski A, Defer G, Derache N, Branger P, Biotti D, Ciron J, Clerc C, Vaillant M, Magy L, Montcuquet A, Kerschen P, Coustans M, Guennoc AM, Brochet B, Ouallet JC, Ruet A, Dulau C, Wiertlewski S, Berger E, Buch D, Bourre B, Pallix-Guiot M, Maurousset A, Audoin B, Rico A, Maarouf A, Edan G, Papassin J, Videt D. Louapre C, et al. Among authors: wiertlewski s. JAMA Neurol. 2020 Sep 1;77(9):1079-1088. doi: 10.1001/jamaneurol.2020.2581. JAMA Neurol. 2020. PMID: 32589189 Free PMC article.
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.
Le Page E, Veillard D, Laplaud DA, Hamonic S, Wardi R, Lebrun C, Zagnoli F, Wiertlewski S, Deburghgraeve V, Coustans M, Edan G; COPOUSEP investigators; West Network for Excellence in Neuroscience. Le Page E, et al. Among authors: wiertlewski s. Lancet. 2015 Sep 5;386(9997):974-81. doi: 10.1016/S0140-6736(15)61137-0. Epub 2015 Jun 28. Lancet. 2015. PMID: 26135706 Free article. Clinical Trial.
[Optic neuritis].
Meyniel C, Wiertlewski S. Meyniel C, et al. Among authors: wiertlewski s. Rev Med Interne. 2010 Jul;31(7):481-5. doi: 10.1016/j.revmed.2009.03.372. Rev Med Interne. 2010. PMID: 20434241 French.
Optic neuritis classification in 2021.
Ducloyer JB, Marignier R, Wiertlewski S, Lebranchu P. Ducloyer JB, et al. Among authors: wiertlewski s. Eur J Ophthalmol. 2021 Jul 3:11206721211028050. doi: 10.1177/11206721211028050. Online ahead of print. Eur J Ophthalmol. 2021. PMID: 34218696
Evaluation of efficacy and tolerability of first-line therapies in NMOSD.
Poupart J, Giovannelli J, Deschamps R, Audoin B, Ciron J, Maillart E, Papeix C, Collongues N, Bourre B, Cohen M, Wiertlewski S, Outteryck O, Laplaud D, Vukusic S, Marignier R, Zephir H; NOMADMUS study group. Poupart J, et al. Among authors: wiertlewski s. Neurology. 2020 Apr 14;94(15):e1645-e1656. doi: 10.1212/WNL.0000000000009245. Epub 2020 Mar 13. Neurology. 2020. PMID: 32170036
Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD.
Zephir H, Poupart J, Deschamps R, Audoin B, Ciron J, Maillart E, Papeix C, Collongues N, Bourre B, Cohen M, Wiertlewski S, Outteryck O, Laplaud D, Vukusic S, Marignier R, Giovannelli J. Zephir H, et al. Among authors: wiertlewski s. Neurology. 2021 Feb 9;96(6):295-296. doi: 10.1212/WNL.0000000000011403. Neurology. 2021. PMID: 33558403 No abstract available.
Predictive medicine in multiple sclerosis: A systematic review.
Havas J, Leray E, Rollot F, Casey R, Michel L, Lejeune F, Wiertlewski S, Laplaud D, Foucher Y. Havas J, et al. Among authors: wiertlewski s. Mult Scler Relat Disord. 2020 May;40:101928. doi: 10.1016/j.msard.2020.101928. Epub 2020 Jan 2. Mult Scler Relat Disord. 2020. PMID: 32004856
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis.
Lejeune F, Chatton A, Laplaud DA, Le Page E, Wiertlewski S, Edan G, Kerbrat A, Veillard D, Hamonic S, Jousset N, Le Frère F, Ouallet JC, Brochet B, Ruet A, Foucher Y, Michel L. Lejeune F, et al. Among authors: wiertlewski s. J Neurol. 2021 Feb;268(2):669-679. doi: 10.1007/s00415-020-10154-5. Epub 2020 Sep 9. J Neurol. 2021. PMID: 32902734
68 results